Table of Contents

company-logo

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Puma Biotechnology Dividend Announcement

• Puma Biotechnology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Puma Biotechnology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Puma Biotechnology Dividend History

Puma Biotechnology Dividend Yield

Puma Biotechnology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Puma Biotechnology stock? Use our calculator to estimate your expected dividend yield:

Puma Biotechnology Financial Ratios

P/E ratio6.96
PEG ratio-0.98
P/B ratio2.28
ROE41.50%
Payout ratio0.00%
Current ratio1.42
Quick ratio1.40
Cash Ratio0.61

Puma Biotechnology Dividend FAQ

Does Puma Biotechnology stock pay dividends?
Puma Biotechnology does not currently pay dividends to its shareholders.
Has Puma Biotechnology ever paid a dividend?
No, Puma Biotechnology has no a history of paying dividends to its shareholders. Puma Biotechnology is not known for its dividend payments.
Why doesn't Puma Biotechnology pay dividends?
There are several potential reasons why Puma Biotechnology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Puma Biotechnology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Puma Biotechnology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Puma Biotechnology a dividend aristocrat?
Puma Biotechnology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Puma Biotechnology a dividend king?
Puma Biotechnology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Puma Biotechnology a dividend stock?
No, Puma Biotechnology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Puma Biotechnology stocks?
To buy Puma Biotechnology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Puma Biotechnology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.